Skip to main content

Bowel Cleansing Prior to Clinical Procedures

1
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Norgine
NorgineAustria - Vienna
1 program
1
PLENVU®Phase 3
Parexel
ParexelMA - Boston
1 program
PLENVU®PHASE_31 trial
Active Trials
NCT07218523Recruiting212Est. Jan 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
ParexelPLENVU®

Clinical Trials (1)

Total enrollment: 212 patients across 1 trials

A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy

Start: Dec 2025Est. completion: Jan 2027212 patients
Phase 3Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 212 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.